Methoxyisoflavone and urine cannabinoid screening: Evidence of a poorly known cross-reactivity;Méthoxyisoflavone et dépistage du cannabis dans les urines: Mise en évidence d'une réaction croisée peu connue

Annales de Toxicologie Analytique

Volumn 24, Issue 1, 2012, Pages 49-58

  Lecompte, Yannick ^a   Perrin, Martine ^a   Daude, Bernard ^b   Arpino, Patrick ^c  

^a INSTITUT GÉOGRAPHIQUE NATIONAL   (France)

^b Centre Medical Interarmees du Commandement de la Gendarmerie de la Reunion Caserne Lambert   (France)

^c PSL RESEARCH UNIVERSITY   (France)

Author keywords

5 methyl 7 methoxyisoflavone; Cannabinoids; Cross reactions; Substance abuse detection

Indexed keywords

5 METHYL 7 METHYLISOFLAVONE; ANTIBODY; CANNABINOID; FLAVONE DERIVATIVE; ISOFLAVONE DERIVATIVE; METHOXYISOFLAVONE; UNCLASSIFIED DRUG;

ACIDITY; ALKALINITY; ANALYTIC METHOD; ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; DERIVATIZATION; DIAGNOSTIC TEST ACCURACY STUDY; DRUG ACETYLATION; DRUG CROSS REACTIVITY; DRUG SCREENING; DRUG URINE LEVEL; ELECTRIC POTENTIAL; ELECTROSPRAY MASS SPECTROMETRY; FALSE POSITIVE RESULT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HYDROLYSIS; IONIZATION; LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY MASS SPECTROMETRY; LIQUID LIQUID EXTRACTION; MASS FRAGMENTOGRAPHY; METABOLITE; NORMAL HUMAN; PH; SILYLATION; TANDEM MASS SPECTROMETRY; URINALYSIS;

EID: 84861728832     PISSN: 0768598X     EISSN: 19619480     Source Type: Journal    
DOI: 10.1051/ata/2012002     Document Type: Article

References (16)

1. Lee H, Roh S, Kim DJ. Alcohol-induced blackout. Int J Environ Res Public Health. 2009; 6(11): 2783-2792.
2. Boucher A, Vilette P, Crassard N, Bernard N, Descotes J. Urinary toxicological screening: Analytical interference between niflumic acid and cannabis. Arch Pediatr. 2009; 16(11): 1457-1460.
3. Delacour H, Servonnet A, Gardet V. Dépistage du cannabis dans les urines, attention á l'acide niflumique. Ann Toxicol Anal. 2005; 17(3): 203-206.
4. Moeller KE, Lee KC, Kissack JC. Urine drug screening: Practical guide for clinicians. Mayo Clin Proc. 2008; 83(1): 66-76.
5. Instruction n° 22000/DEF/GEND/RH du 13 février 2008 relative aux normes d'aptitude médicale des personnels militaires de la gendarmerie 2008.
6. Feinberg M, Boulanger B, Dewe W, Hubert P. New advances in method validation and measurement uncertainty aimed at improving the quality of chemical data. Anal Bioanal Chem. 2004; 380(3): 502-514.
7. Yoshida K, Tsukamoto T, Torii H, Doi T, Naeshiro I, Uemura I, Tanayama S. Metabolism of ipriflavone (TC-80) in rats. Radioisotopes. 1985; 34(11): 612-617.
8. Heinonen SM, Wähälä K, Adlercreutz H. Metabolism of isoflavones in human subjects. Phytochemistry Reviews. 2002; 1(2): 175-182.
9. Kreider RB, Wilborn CD, Taylor L, Campbell B, Almada AL, Collins R, Cooke M, Earnest CP, Greenwood M, Kalman DS, Kerksick CM, Kleiner SM, Leutholtz B, Lopez H, Lowery LM, Mendel R, Smith A, Spano M, Wildman R, Willoughby DS, Ziegenfuss TN, Antonio J. ISSN exercise &sport nutrition review: research &recommendations. J Int Soc Sports Nutr. 2010; 7: 7-50.
10. Feuer L, Farkas L, Nogradi M, Vermes B, Gottsegen A, Wolfner A. Metabolic 5-methyl-isoflavone-derivatives, process for the preparation thereof and compositions containing the same. US patent 4163746. 1979.
11. Incledon T, Van Gammeren D, Antonio J. The effects of 5-methyl- 7-methoxyisoflavone on body composition and performance in college-aged men. Med Sci Sports Exer. 2001; 33(5): S338.
12. WilbornCD,TaylorLW,CampbellBI,KerksickC,RasmussenCJ, Greenwood M, Kreider RB. Effects of methoxyisoflavone, ecdysterone, and sulfo-polysaccharide supplementation on training adaptations in resistance-trained males. J Int Soc Sports Nutr. 2006; 3: 19-27.
13. Dumestre-TouletV.Sedoper via Internet ?Unjeudesouris !Ann Toxicol Anal. 2000; 12(1): 19-25.
14. Monostory K, Vereczkey L, Levai F, Szatmari I. Ipriflavone as an inhibitor of human cytochrome P450 enzymes. Br J Pharmacol. 1998; 123(4): 605-610.
15. Lecompte Y, Salle S, Roussel O, Hervé S, Messines O, Perrin M. Influence du seuil de confirmation lors du dépistage urinaire de l'usage du cannabis : á propos de cinq années de dépistages réalisés au sein de la Gendarmerie nationale. Médecine et Armées. 2011; 39(4): 35-46.
16. CEDIA® THC Cross-Reactivity Table. Document consulté sur le site https://fscimage.fishersci.com/images/D15921~.pdf le 21 novembre 2011.